Clinical Trials in Tennessee

Showing 10321-10340 of 20,239 trials

Dual Versus Triple Protease Inhibitor Combinations, Including Ritonavir, in HIV Infected People

NCT00028366

Ritonavir (RTV) is a protease inhibitor (PI) commonly used to increase drug levels of other PIs in HIV drug treatment. The purpose of this study is to compare a combination of drugs which includes RTV and 2 protease inhibitors (PIs) with 2 combinations that include RTV and another PI. This study also will compare the effectiveness, safety, tolerability, and drug levels in the blood of these anti-HIV drug combinations.

HIV Infections

National Institute of Allergy and Infectious Diseases (NIAID)56 participants

Los Angeles, California, United States • San Francisco, California, United States • Atlanta, Georgia, United States +10 more locations

COMPLETEDPhase 329 miles

Stem Cell Transplantation in Individuals With Multiple Myeloma (BMT CTN 0102)

NCT00075829

The study is designed as a Phase III, multi-center trial of tandem autologous transplants versus the strategy of autologous followed by Human Leukocyte Antigen (HLA)-matched sibling non-myeloablative allogeneic transplant. Study subjects will be biologically assigned to the appropriate arm depending on the availability of an HLA-matched sibling. There is a nested randomized phase III trial of observation versus maintenance therapy following the second autologous transplant for patients on the tandem autologous transplant arm.

Multiple Myeloma

National Heart, Lung, and Blood Institute (NHLBI)710 participantsStarted Dec 2003

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Duarte, California, United States +33 more locations

Dual Versus Triple Protease Inhibitor Combinations, Including Ritonavir, in HIV Infected People

Stem Cell Transplantation in Individuals With Multiple Myeloma (BMT CTN 0102)

Find Trials by Condition in Tennessee

Safety and Effectiveness of the Oral HIV Entry Inhibitor Vicriviroc in HIV Infected Patients

Combination Treatment With and Without Protease Inhibitors for Women Who Begin Therapy for HIV Infection During Pregnancy

A Study to Evaluate Steroid-free Treatment for Standard-Risk aGVHD (BMT CTN 1501)

Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis

Safety and Pharmacokinetics (PK) of Raltegravir in HIV (Human Immunodeficiency Virus)-Infected Children and Adolescents

Quadrivalent HPV Vaccine to Prevent Anal HPV in HIV-infected Men and Women

A Randomized, Double Blind, Comparative Study of Dideoxycytidine (ddC) Alone or ddC/AZT Combination Versus Zidovudine (ZDV) Alone in Patients With HIV Infection Who Have Received Prior ZDV Therapy

Testosterone for HIV-Positive Men With Reduced Serum Testosterone Levels and Abdominal Fat

A Study of Megestrol Acetate Alone or in Combination With Testosterone Enanthate Drug in the Treatment of HIV-Associated Weight Loss

The Safety and Effectiveness of Hydroxyurea and ddI Used Individually or Together in HIV-Infected Patients

A Study of DAPD Alone Versus DAPD Plus MMF for Treatment of HIV Infection

An Efficacy, Safety, and Pharmacokinetics Study of Subcutaneously Administered Ustekinumab in the Treatment of Moderate to Severe Chronic Plaque Psoriasis in Pediatric Participants Greater Than or Equal to 6 to Less Than 12 Years of Age

EndoRotor DEN (Direct Endoscopic Necrosectomy)Trial

Safety of the Candidate Vaccine C4-V3 Alone or With Interleukin-12 (IL-12) in HIV-Infected Patients Receiving Effective Anti-HIV Drug Therapy

The Effects of Anti-HIV Drugs in HIV-Infected Patients Who Do Not Have AIDS

A Phase I/II Open Label Study To Evaluate the Antiviral Potential of Combination Low-Dose Therapy With Zidovudine and Interferon-Alpha 2A in Patients With Symptomatic HIV Disease

Adding New Drugs for HIV Infected Patients Failing Current Therapy

The Effectiveness of Two Anti-HIV Treatments in HIV-Infected Patients